Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	3657	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	5224	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	5642	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	5646	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	6893	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	6896	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	7181	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	8045	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	8286	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	8382	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	8591	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	8873	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9072	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9082	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9310	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9406	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9577	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9592	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9861	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	9893	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	10007	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	10184	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	10278	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	10290	Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	10292	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	10395	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	11167	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	11207	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	11480	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	11486	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	11677	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	11883	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12050	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12129	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12173	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12242	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12269	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12844	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	12853	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13001	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13013	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13128	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13241	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13308	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13320	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13368	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13413	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13575	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13667	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	13790	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14138	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14422	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14468	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14518	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14616	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14707	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14907	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14995	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	14997	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	15017	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	15050	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	15888	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	17002	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	17006	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	17310	Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	17417	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	18226	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	18422	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	18609	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	19182	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	20001	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	20202	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	20480	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	20741	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	20921	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	21053	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	21183	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	21620	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	21802	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	22589	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	22781	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	23126	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	23154	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	23346	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	24388	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	24959	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	25537	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	25770	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	27035	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	27446	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	27606	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	27832	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	29300	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	30412	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	30605	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	31879	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	32569	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	33389	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	40329	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase NEGATIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M-H)-	47231	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+	1282	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	ARACHIDIC ACID (CAS# 506-30-9); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y